Georgia Tech fell short in the Atlanta regional earlier this week, but James Ramsey is wasting no time trying to reload for next season. Ramsey and the Yellow Jackets picked up their first big ...

While Novo Nordisk was first to market with GLP-1 weight-loss drugs, it faced supply constraints. That opened the U.S. market up to generic competition earlier than normal, hampering the company's ...

Eli Lilly has given some 340B hospitals five business days to begin submitting claims-level data or risk losing access to discounted drug pricing, escalating a growing dispute over transparency ...

Referential, silly, and filled with trans angst, the pop singer’s debut album gets a deluxe reissue with a handful of new tracks that blend Radio Disney pastiche and 2000s R&B-pop. The deluxe edition ...

The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens. By Rebecca Robbins Eli Lilly said on Tuesday that ...

The semi-slow period on the NFL calendar affords time to take a trip in the wayback machine, 22 years to the spring of 2004, when Eli Manning was a fresh-faced Ole Miss product entering the draft. The ...

PHILADELPHIA — The Eagles selected Vanderbilt tight end Eli Stowers with the 54th pick in the second round on Friday. Stowers is a move tight end who has tremendous upside as a pass catcher. He has ...

Former two-time Super Bowl-winning NY Giants quarterback Eli Manning helped TCL kick off a glitzy New York launch event for the company’s latest premium TVs, leaning into the company’s positioning of ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Eli Lilly (LLY) is in advanced negotiations to acquire Kelonia Therapeutics in a transaction valued at more than $2 billion, The Wall Street Journal reported Sunday, citing people familiar with the ...

Novo Nordisk generates the majority of its revenue from its GLP-1 franchise. The company's semaglutide, marketed under brands such as Wegovy for weight loss and Ozempic for diabetes, has been a market ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment shows lingering reservations about multiple "unexpected serious" risks ...